Session Track · Dental 2027

Oropharyngeal cancers at Dental 2027

Part of the Dental 2027 scientific programme · Village Hotel Changi, Singapore · March 15–17, 2027

About the Oropharyngeal cancers Session

Oropharyngeal cancer is the 6th most common type of cancer worldwide and is divided into two main types: squamous cell carcinoma, which is the most common, and non-squamous cell carcinoma. Risk factors for oropharyngeal cancer include tobacco use, heavy alcohol consumption, poor oral hygiene, human papillomavirus (HPV) infection, and exposure to certain toxins. It is more common in men than women, in those over 50 years of age, and in those with a family history of the disease. Symptoms of oropharyngeal cancer may include a lump or sore in the throat that does not go away, difficulty swallowing, pain in the throat or ears, neck pain, and voice changes. It is important to see a doctor if you experience any of these symptoms. Diagnosis for oropharyngeal cancer is typically done with a physical exam and biopsy. Imaging tests such as x-rays and CT scans may also be used. Treatment options vary depending on the stage of the cancer and may include surgery, radiation, chemotherapy, and targeted therapy. It is important to take steps to reduce your risk of oropharyngeal cancer.

Topics Covered in Oropharyngeal cancers

Topic 01

HPV-Positive Tumors

Topic 02

Tonsillar & Tongue Base Tumors

Topic 03

Dysphagia & Voice Changes

Topic 04

Transoral Robotic Surgery

Topic 05

Chemoradiotherapy

Topic 06

Pre-Radiotherapy Dental Assessment

Related Scientific Sessions at Dental 2027

Why Attend the Oropharyngeal cancers Conference 2027

Earn CPD Credit

Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.

Present Your Research

Oral and poster slots for original Oropharyngeal cancers work, reviewed by the scientific committee.

Network Globally

Meet dentists, oral-health researchers, and clinical leaders from around the world across three days.

Publish & Get Indexed

Accepted abstracts appear in the indexed conference proceedings with a citable DOI.

Learn from Keynotes

Plenary lectures from leading voices shaping Oropharyngeal cancers research and practice.

Hybrid Flexibility

Attend in person in Singapore or join virtually — same programme, same certificate.

Join Dental 2027 for the Oropharyngeal cancers track

Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.

Oropharyngeal cancers Conference 2027 — FAQs

What is the Oropharyngeal cancers track at Dental 2027?

The Oropharyngeal cancers track is a dedicated stream within Dental 2027 covering the latest research, clinical innovation, and best practice in Oropharyngeal cancers. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Oropharyngeal cancers sessions?

Educators, doctoral students, and dentists, oral-health researchers, and clinical leaders with an interest in Oropharyngeal cancers are all welcome — whether presenting or attending.

Can I present my research in the Oropharyngeal cancers track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Oropharyngeal cancers sessions?

Yes. Dental 2027 is a hybrid conference — attend the Oropharyngeal cancers track in person in Singapore or join live online, with on-demand access afterward.

Join the Dental 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us